| Non-Alcoholic Fatty Liver Disease |
1 |
1 |
| Biliary Disease |
0 |
1 |
| Metabolic Syndrome |
0 |
1 |
| Liver |
0 |
0.77 |
| Fatty Liver |
0 |
0.73 |
| Aminotransferase |
0 |
0.61 |
| Liver Disease |
0 |
0.61 |
| Obesity |
0 |
0.59 |
| Hepatic Fibrosis |
0 |
0.57 |
| Liver Biopsy |
0 |
0.54 |
| Bariatric Surgery |
0 |
0.46 |
| Hepatocellular Carcinoma |
0 |
0.46 |
| Surgery |
0 |
0.34 |
| Cerebrovascular Accident |
0 |
0.29 |
| Thromboembolism |
0 |
0.26 |
| Cirrhosis |
0 |
0.24 |
| Heart Failure (HF) |
0 |
0.22 |
| Weight Loss |
0 |
0.19 |
| Vitamin |
0 |
0.18 |
| Thyroid Disease |
0 |
0.17 |
| Weight Management |
0 |
0.16 |
| Hypertension |
0 |
0.15 |
| Sleep Apnea |
0 |
0.15 |
| Sleep Disorders |
0 |
0.15 |
| Indiana |
0 |
0.14 |
| Biopsy |
0 |
0.13 |
| Cardiometabolic Risk Factors |
0 |
0.13 |
| Child |
0 |
0.13 |
| Steatosis |
0 |
0.13 |
| Lipids Management |
0 |
0.12 |
| Type 2 Diabetes Mellitus |
0 |
0.12 |
| Cardiovascular Risk Management |
0 |
0.11 |
| Exercise |
0 |
0.1 |
| Coronary Artery Disease (CAD) |
0 |
0.08 |
| Body Mass Index |
0 |
0.06 |
| Cancer |
0 |
0.06 |
| Congestive Heart Failure |
0 |
0.06 |
| Meta-Analysis |
0 |
0.06 |
| Statins |
0 |
0.06 |
| Cardiovascular disease |
0 |
0.05 |
| Diet |
0 |
0.05 |
| Fatty Acids |
0 |
0.05 |
| Food and Drug Administration (FDA) |
0 |
0.05 |
| Heart |
0 |
0.05 |
| Hemorrhagic Stroke |
0 |
0.05 |
| Histology |
0 |
0.05 |
| Hyperlipidemia |
0 |
0.05 |
| Metabolism |
0 |
0.05 |
| Receptors |
0 |
0.05 |
| Biologic Therapy |
0 |
0.04 |
| Bladder Cancer |
0 |
0.04 |
| Prostate Cancer |
0 |
0.04 |
| Clinical Research |
0 |
0.03 |
| Fractures |
0 |
0.03 |
| Genomic Medicine |
0 |
0.03 |
| Injury |
0 |
0.03 |
| Inpatient Care |
0 |
0.03 |
| Insulin Resistance |
0 |
0.03 |
| Internship |
0 |
0.03 |
| Ischemic Stroke |
0 |
0.03 |
| Nonalcoholic Steatohepatitis |
0 |
0.03 |
| Obstructive Sleep Apnea |
0 |
0.03 |
| Patient Safety |
0 |
0.03 |
| Perioperative Care |
0 |
0.03 |
| Sleep |
0 |
0.03 |
| Adherence |
0 |
0.02 |
| Adverse Effects |
0 |
0.02 |
| Anatomy |
0 |
0.02 |
| Anticoagulation Therapy |
0 |
0.02 |
| Antihypertensive Agents |
0 |
0.02 |
| Antioxidant |
0 |
0.02 |
| Bladder |
0 |
0.02 |
| Bone |
0 |
0.02 |
| Clinical Guidelines |
0 |
0.02 |
| Cytology |
0 |
0.02 |
| Diagnostic and Statistical Manual of Mental Disorders |
0 |
0.02 |
| Dyslipidemia |
0 |
0.02 |
| Endoscopy |
0 |
0.02 |
| Gastrectomy |
0 |
0.02 |
| Gastric Bypass |
0 |
0.02 |
| Genetics |
0 |
0.02 |
| Glycemic Index |
0 |
0.02 |
| Healthcare and Medical Technology |
0 |
0.02 |
| Hospital |
0 |
0.02 |
| LDL Cholesterol |
0 |
0.02 |
| Magnetic Resonance Imaging |
0 |
0.02 |
| Multidisciplinary Team |
0 |
0.02 |
| Ovary |
0 |
0.02 |
| Physiology |
0 |
0.02 |
| Polycystic Ovary Syndrome |
0 |
0.02 |
| Portal Hypertension |
0 |
0.02 |
| Preventive Screening |
0 |
0.02 |
| Primary Care |
0 |
0.02 |
| Prostate |
0 |
0.02 |
| Pruritus |
0 |
0.02 |
| Surgical Complication |
0 |
0.02 |
| Triglycerides |
0 |
0.02 |
| Varices |
0 |
0.02 |
| Weight Gain |
0 |
0.02 |
| Wound Management |
0 |
0.02 |
| Hypothyroidism |
0 |
0.01 |
| Infertility Female |
0 |
0.01 |
| Multiple Sclerosis |
0 |
0.01 |